Twist Bioscience (TWST) Change in Cash (2017 - 2026)

Twist Bioscience has disclosed Change in Cash across 10 years of filings, most recently posting -$26.1 million for Q1 2026.

• In Q1 2026, Change in Cash fell 135.18% year-over-year to -$26.1 million; the TTM figure through Mar 2026 stood at -$88.1 million (down 164.8% YoY), while the FY2025 annual figure was -$43.7 million, up 27.34% from the prior year.
• Change in Cash advanced to -$26.1 million in Q1 2026, from -$34.4 million in the prior quarter.
• Over the last five years, Change in Cash for TWST reached as high as $216.0 million in Q1 2022 and fell as low as -$61.2 million in Q4 2022.
• The 5-year median for Change in Cash is -$12.9 million (2024), against an average of -$4.0 million.
• Annual changes were most pronounced in 2022 — Change in Cash soared 327.39% — and 2024, when it plunged 1396.73%.
• A 5-year view of Change in Cash shows it stood at -$61.2 million in 2022, then jumped by 67.03% to -$20.2 million in 2023, then soared by 74.84% to -$5.1 million in 2024, then sank by 578.89% to -$34.4 million in 2025, then climbed by 24.12% to -$26.1 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$26.1 million, -$34.4 million, and -$18.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.